Elevated Lipoprotein Lipase Activity Does Not Account for the Association Between Adiponectin and HDL in Type 1 Diabetes.
暂无分享,去创建一个
[1] R. Goldberg,et al. High HDL-C prevalence is common in type 1 diabetes and increases with age but is lower in Hispanic individuals. , 2015, Journal of diabetes and its complications.
[2] E. Barrett-Connor,et al. Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. , 2013, The Journal of clinical endocrinology and metabolism.
[3] S. Yamashita,et al. Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography. , 2012, Metabolism: clinical and experimental.
[4] M. Rewers,et al. Adiponectin dysregulation and insulin resistance in type 1 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.
[5] Merlin C. Thomas,et al. Serum adiponectin concentration is a positive predictor of all‐cause and cardiovascular mortality in type 1 diabetes , 2011, Journal of internal medicine.
[6] T. Orchard,et al. High-density lipoprotein cholesterol in diabetes: is higher always better? , 2011, Journal of clinical lipidology.
[7] J. Saltevo,et al. High serum adiponectin is associated with favorable lipoprotein subclass profile in 6.4-year follow-up. , 2011, European journal of endocrinology.
[8] C. Tschöpe,et al. Impact of HDL on adipose tissue metabolism and adiponectin expression. , 2010, Atherosclerosis.
[9] J. Frystyk,et al. Adiponectin and Lipoprotein Particle Size , 2009, Diabetes Care.
[10] J. Shao,et al. Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism , 2008, Diabetes.
[11] J. Hokanson,et al. Determinants of serum adiponectin in persons with and without type 1 diabetes. , 2007, American journal of epidemiology.
[12] Michael J Pencina,et al. Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study , 2007, Circulation.
[13] P. Gambert,et al. Adiponectin Is an Important Determinant of ApoA-I Catabolism , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[14] J. Schneider,et al. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. , 2005, Diabetes care.
[15] B. Wolffenbuttel,et al. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects. , 2005, Clinical laboratory.
[16] J. Schneider,et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. , 2004, Diabetes care.
[17] T. Orchard,et al. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study , 2004, Diabetologia.
[18] U. Müller-Ladner,et al. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL‐cholesterol levels in type 2 diabetes , 2003, FEBS letters.
[19] M. Cnop,et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.
[20] S. Kihara,et al. Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.
[21] T. Funahashi,et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. , 2002, Diabetes care.
[22] C. Bouchard,et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[23] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[24] J. Zhi,et al. Orlistat fails to alter postprandial plasma lipid excursions or plasma lipases in normal-weight male volunteers , 2000, International Journal of Obesity.
[25] R. Holman,et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.
[26] A. Tall. Metabolic and genetic control of HDL cholesterol levels , 1992, Journal of internal medicine.
[27] Robert V Farese,et al. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. , 1991, Metabolism: clinical and experimental.
[28] T. A. Hughes,et al. Rapid quantitative apolipoprotein analysis by gradient ultracentrifugation and reversed-phase high performance liquid chromatography. , 1988, Journal of lipid research.
[29] L. Rand,et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. , 1987, The American journal of cardiology.
[30] E. Nikkilä,et al. Serum Lipids and Lipoproteins in Insulin-treated Diabetes: Demonstration of Increased High Density Lipoprotein Concentrations , 1978, Diabetes.